Form 4: Prestige Consumer Healthcare Exec Trades Shares

Ronald M. Lombardi, CEO and Director of Prestige Consumer Healthcare Inc., reported a transaction involving the acquisition of 2,543 shares of common stock.

Summary

• Ronald M. Lombardi, Chief Executive Officer and Director of Prestige Consumer Healthcare Inc. (PBH), reported a transaction on May 7, 2026.
• The transaction involved the acquisition of 2,543 shares of common stock at a price of $54.59 per share.
• Following this transaction, Mr. Lombardi beneficially owns 373,465 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider transaction without explicit positive or negative financial implications disclosed.

Positives

• The CEO and Director acquired additional shares, indicating potential confidence in the company's future prospects.
• The acquisition was made at a specific price point, suggesting a planned investment rather than a market reaction.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into executive investment decisions. Such filings are closely watched by investors as potential indicators of management's view on the company's valuation and prospects.

Stakeholder Impact

• Shareholders: The acquisition by the CEO may be interpreted as a positive signal of confidence in the company's future performance.
• Employees: May view the CEO's investment as a sign of stability and growth potential.
• Creditors: No direct impact is indicated by this transaction.

Key Dates

Keywords

SEC Form 4, Insider Trading, Prestige Consumer Healthcare, PBH, Ronald M. Lombardi, Common Stock, Beneficial Ownership, Executive Transactions